Note: Ingredients listed on restricted chemical lists
EC/CAS
104653-34-1
Name of the chemical
Difethialon (ISO); 3-[3-(4′-Brombiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1- yl]-4-hydroxy-2H-1-benzothiopyran-2-on (2016/1179)
Concentration
N/A
General Information
Product name
disposing of dead rodents, unconsumed bait and empty containers. No
Product Synonyms
Anticoagulant rodenticide with Difethialone
CAS No.
104653-34-1
Manufacturer Name
liphatech, inc
Icons in SDS
Company Information
company name
liphatech, inc
Section 2
SECTION 2: Hazards identification
ph: Not applicable % Volatile (Volume): Vapor density: Not applicable Vapor Pressure: Not applicable emergency overview: May be harmful or fatal if swallowed or absorbed Boiling Point: Not applicable Freezing Point: Not applicable through the skin, because this material may reduce the clotting ability of the blood and cause bleeding. Partition coefficient (n-octanol/water): Not applicable
Principle Routes of Exposure
Oral (swallowing), dermal (absorption through skin) Flash point (astM d92): >190 oC. acute effects (signs and symptoms of overexposure): auto-ignition temperature: Not determined - eyes: May cause temporary eye irritation. explosive limits lower limit Not applicable, Upper limit Not applicable - skin: May be harmful if absorbed through skin. Symptoms of toxicity sensitivity to mechanical shock or static discharge: Not applicable include lethargy, loss of appetite, reduced blood clotting ability and bleeding. - inhalation: Due to this product’s solid form, inhalation is unlikely. staBility and reactiVity - ingestion: May be harmful if swallowed. Symptoms of toxicity include conditions of chemical instability: None lethargy, loss of appetite, reduced clotting ability of blood, and bleeding. name of substance or class which is incompatible: None
Potential chronic health
Prolonged and/or repeated exposure to small amounts of conditions of reactivity: None product can produce cumulative toxicity. Symptoms of toxicity include hazardous Products of decomposition: Oxides of carbon lethargy, loss of appetite, reduced clotting ability of blood, and bleeding. May aggravate existing bleeding disorders.